An episomal DNA vector platform for the persistent genetic modification of pluripotent stem cells and their differentiated progeny.

[1]  R. Offringa,et al.  Novel Non-integrating DNA Nano-S/MAR Vectors Restore Gene Function in Isogenic Patient-Derived Pancreatic Tumor Models , 2020, Molecular therapy. Methods & clinical development.

[2]  N. Rosenblum,et al.  Generation of infant- and pediatric-derived urinary induced pluripotent stem cells competent to form kidney organoids , 2019, Pediatric Research.

[3]  T. Rausch,et al.  A highly soluble Sleeping Beauty transposase improves control of gene insertion , 2019, Nature Biotechnology.

[4]  Patrycja Czerwińska,et al.  Gene delivery methods and genome editing of human pluripotent stem cells. , 2019, Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology.

[5]  D. Wells,et al.  Episomal minicircles persist in periods of transcriptional inactivity and can be transmitted through somatic cell nuclear transfer into bovine embryos , 2019, Molecular Biology Reports.

[6]  I. Slukvin,et al.  Genetic Engineering of Human Pluripotent Stem Cells Using PiggyBac Transposon System. , 2018, Current protocols in stem cell biology.

[7]  S. Ramakrishna,et al.  Genome Editing in Stem Cells for Disease Therapeutics , 2018, Molecular Biotechnology.

[8]  H. Lipps,et al.  Genome-wide profiling of S/MAR-based replicon contact sites , 2017, Nucleic acids research.

[9]  K. Rohr,et al.  Phosphorylation-Dependent Feedback Inhibition of RIG-I by DAPK1 Identified by Kinome-wide siRNA Screening. , 2017, Molecular cell.

[10]  J. Ju,et al.  CRISPR-Cas9: a promising tool for gene editing on induced pluripotent stem cells , 2017, The Korean journal of internal medicine.

[11]  Roland Eils,et al.  Complex heatmaps reveal patterns and correlations in multidimensional genomic data , 2016, Bioinform..

[12]  G. Smyth,et al.  ROBUST HYPERPARAMETER ESTIMATION PROTECTS AGAINST HYPERVARIABLE GENES AND IMPROVES POWER TO DETECT DIFFERENTIAL EXPRESSION. , 2016, The annals of applied statistics.

[13]  David V Schaffer,et al.  Viral Vectors for Gene Therapy: Translational and Clinical Outlook. , 2015, Annual review of biomedical engineering.

[14]  A. Schambach,et al.  A minimal ubiquitous chromatin opening element (UCOE) effectively prevents silencing of juxtaposed heterologous promoters by epigenetic remodeling in multipotent and pluripotent stem cells , 2015, Nucleic acids research.

[15]  Matthew E. Ritchie,et al.  limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.

[16]  A. Schambach,et al.  All-in-One inducible lentiviral vector systems based on drug controlled FLP recombinase. , 2014, Biomaterials.

[17]  C. Templin,et al.  Fast and efficient multitransgenic modification of human pluripotent stem cells. , 2014, Human gene therapy methods.

[18]  Y. Agca,et al.  Short-term storage of rat sperm in the presence of various extenders. , 2013, Journal of the American Association for Laboratory Animal Science : JAALAS.

[19]  H. Lipps,et al.  Genomic cis-acting Sequences Improve Expression and Establishment of a Nonviral Vector , 2013, Molecular therapy. Nucleic acids.

[20]  Shinya Yamanaka,et al.  Induced pluripotent stem cells in medicine and biology , 2013, Development.

[21]  A. Schambach,et al.  A ubiquitous chromatin opening element prevents transgene silencing in pluripotent stem cells and their differentiated progeny , 2013, Stem cells.

[22]  A. Paradowska,et al.  Analysing the sperm epigenome: roles in early embryogenesis and assisted reproduction , 2012, Nature Reviews Urology.

[23]  Johannes E. Schindelin,et al.  Fiji: an open-source platform for biological-image analysis , 2012, Nature Methods.

[24]  B. Faircloth,et al.  Primer3—new capabilities and interfaces , 2012, Nucleic acids research.

[25]  A. Baiker,et al.  Handling S/MAR vectors. , 2012, Cold Spring Harbor protocols.

[26]  C. von Kalle,et al.  Extensive methylation of promoter sequences silences lentiviral transgene expression during stem cell differentiation in vivo. , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

[27]  Yasuko Matsumura,et al.  A more efficient method to generate integration-free human iPS cells , 2011, Nature Methods.

[28]  Christopher Baum,et al.  Lentiviral vector design and imaging approaches to visualize the early stages of cellular reprogramming. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

[29]  S. Wong,et al.  Development of S/MAR minicircles for enhanced and persistent transgene expression in the mouse liver , 2011, Journal of Molecular Medicine.

[30]  Wei Shi,et al.  Optimizing the noise versus bias trade-off for Illumina whole genome expression BeadChips , 2010, Nucleic acids research.

[31]  J. Deng,et al.  PiggyBac transposon-mediated, reversible gene transfer in human embryonic stem cells. , 2010, Stem cells and development.

[32]  A. Baiker,et al.  pEPito: a significantly improved non-viral episomal expression vector for mammalian cells , 2010, BMC biotechnology.

[33]  M. Gerstein,et al.  EBNA1 regulates cellular gene expression by binding cellular promoters , 2009, Proceedings of the National Academy of Sciences.

[34]  James A. Williams,et al.  Improved antibiotic-free DNA vaccine vectors utilizing a novel RNA based plasmid selection system. , 2009, Vaccine.

[35]  Sean J Morrison,et al.  Mechanisms of stem cell self-renewal. , 2009, Annual review of cell and developmental biology.

[36]  Z. Izsvák,et al.  EMBRYONIC STEM CELLS/INDUCED PLURIPOTENT STEM CELLS Applying a ‘‘Double-Feature’’ Promoter to Identify Cardiomyocytes Differentiated from Human Embryonic Stem Cells Following Transposon-Based Gene Delivery , 2009 .

[37]  M. Rao,et al.  A single EBV-based vector for stable episomal maintenance and expression of GFP in human embryonic stem cells. , 2009, Regenerative medicine.

[38]  A. Miller,et al.  Persistent episomal transgene expression in liver following delivery of a scaffold/matrix attachment region containing non-viral vector , 2008, Gene Therapy.

[39]  Jonathan L. Linehan,et al.  Efficient and Stable Transgene Expression in Human Embryonic Stem Cells Using Transposon‐Mediated Gene Transfer , 2007, Stem cells.

[40]  Alessandro Aiuti,et al.  Hot spots of retroviral integration in human CD34+ hematopoietic cells. , 2007, Blood.

[41]  T. Cremer,et al.  Establishment and mitotic stability of an extra-chromosomal mammalian replicon , 2007, BMC Cell Biology.

[42]  R. Manservigi,et al.  An S/MAR-based infectious episomal genomic DNA expression vector provides long-term regulated functional complementation of LDLR deficiency , 2007, Nucleic acids research.

[43]  Maido Remm,et al.  Enhancements and modifications of primer design program Primer3 , 2007, Bioinform..

[44]  M. Papa,et al.  Genetically modified pigs produced with a nonviral episomal vector , 2006, Proceedings of the National Academy of Sciences.

[45]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[46]  R. Bartenschlager,et al.  Characterization of the Early Steps of Hepatitis C Virus Infection by Using Luciferase Reporter Viruses , 2006, Journal of Virology.

[47]  P. Tesar.  Derivation of germ-line-competent embryonic stem cell lines from preblastocyst mouse embryos. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[48]  W. Hammerschmidt,et al.  The EBV nuclear antigen 1 (EBNA1) enhances B cell immortalization several thousandfold , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[49]  Christof von Kalle,et al.  A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. , 2003, The New England journal of medicine.

[50]  Xian-Yang Zhang,et al.  Lentiviral vectors for sustained transgene expression in human bone marrow-derived stromal cells. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

[51]  F. Jönsson,et al.  An episomally replicating vector binds to the nuclear matrix protein SAF‐A in vivo , 2002, EMBO reports.

[52]  F. Marks,et al.  Abnormal differentiation of epidermis in transgenic mice constitutively expressing cyclooxygenase-2 in skin , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[53]  D. Trono,et al.  Self-Inactivating Lentivirus Vector for Safe and Efficient In Vivo Gene Delivery , 1998, Journal of Virology.

[54]  Johann Meyer,et al.  Host cis-Mediated Extinction of a Retrovirus Permissive for Expression in Embryonal Stem Cells during Differentiation , 1998, Journal of Virology.

[55]  Luigi Naldini,et al.  Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo , 1997, Nature Biotechnology.

[56]  Yamamura Ken-ichi,et al.  Expression vector system based on the chicken β-actin promoter directs efficient production of interleukin-5 , 1989 .

[57]  M. Monk,et al.  HPRT-deficient (Lesch–Nyhan) mouse embryos derived from germline colonization by cultured cells , 1987, Nature.

[58]  J. Yates,et al.  A vector that replicates as a plasmid and can be efficiently selected in B-lymphoblasts transformed by Epstein-Barr virus , 1985, Molecular and cellular biology.

[59]  M. Kaufman,et al.  Establishment in culture of pluripotential cells from mouse embryos , 1981, Nature.

[60]  H. Lipps,et al.  pEPI for Gene Therapy Non viral episomes and their Application in Somatic Gene Therapy , 2013 .

[61]  O. Argyros,et al.  Non-viral S/MAR vectors replicate episomally in vivo when provided with a selective advantage , 2011, Gene Therapy.

[62]  I. Verma,et al.  Production and purification of lentiviral vectors , 2006, Nature Protocols.

[63]  E. Papapetrou,et al.  Gene transfer into human hematopoietic progenitor cells with an episomal vector carrying an S/MAR element , 2006, Gene Therapy.

[64]  A. Baiker,et al.  Exploiting a minimal system to study the epigenetic control of DNA replication: the interplay between transcription and replication , 2004, Chromosome Research.

[65]  Alex E. Lash,et al.  Gene Expression Omnibus: NCBI gene expression and hybridization array data repository , 2002, Nucleic Acids Res..

[66]  A. Baiker,et al.  A vector based on the SV40 origin of replication and chromosomal S/MARs replicates episomally in CHO cells. , 1999, Nucleic acids research.

[67]  J. Pagano,et al.  Molecular Mechanisms of Transformation by Epstein-Barr Virus , 1995 .

[68]  N. Davidson,et al.  Activating elements in the promoter region of the chicken β-actin gene , 1986 .

[69]  J. Yates,et al.  Stable replication of plasmids derived from Epstein–Barr virus in various mammalian cells , 1985, Nature.